ResMed, Inc. (RMD)
251.51
-9.28
(-3.56%)
USD |
NYSE |
Feb 24, 16:00
251.51
0.00 (0.00%)
After-Hours: 20:00
ResMed EPS Diluted (Quarterly) : 2.682 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Abbott Laboratories | 1.030 |
| Baxter International, Inc. | -2.160 |
| Stryker Corp. | 2.197 |
| Globus Medical, Inc. | 0.8787 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 392.59M |
| Revenue (Quarterly) | 1.423B |
| Total Expenses (Quarterly) | 1.030B |
| Enterprise Value | 37.41B |
| Gross Profit Margin (Quarterly) | 60.93% |
| Profit Margin (Quarterly) | 27.59% |
| Earnings Yield | 4.02% |
| Operating Earnings Yield | 5.00% |
| Normalized Earnings Yield | 4.062 |